Glycomine
BioTech/Drugs - San Carlos, CA, US
Glycomine Details
Glycomine is developing orphan drugs for serious rare disorders of metabolism and protein misfolding for which no other therapeutic options exist. The company's approach is to use replacement therapies – substrates, enzymes, or proteins – and to target those molecules to clinically relevant cellular compartments. Glycomine's lead drug candidate, GLM101, is a novel substrate replacement therapy in development to treat phosphomannomutase 2-congenital disorder of glycosylation (PMM2-CDG), a rare disease representing a critical unmet medical need.
Website:
glycomine.com
Employees:
10 - 19
HQ:
650-401-2016
Location:
San Carlos, CA, US
Revenue:
1 - 2.5 Million
Glycomine Technologies
Email Providers
Outlook
Load Balancers
Nginx
CMS
WP Engine
Fonts
Google Font API
Other
Microsoft Office 365
Hosting
Google Cloud Hosting